Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaDocumentoPhase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaAgregado por Shiro0 calificaciones0% encontró este documento útilGuardar Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS Lymphoma para después